Table 1 of Abu El-Asrar, Mol Vis 2010; 16:1098-1107. Table 1 of Abu El-Asrar, Mol Vis 2010; 16:1098-1107.
Table 1. Monoclonal and polyclonal antibodies used in this study.
| Primary antibody | Dilution | Incubation time | Source* |
|---|---|---|---|
| Anti-CD34 (Clone My 10) (mc) | 1/50 | 60 min | BD Biosciences |
| Anti-c- kit (Code A4502 (pc) | 1/20 | 60 min | Dako |
| Anti-SCF (Catalogue No. AB-255-NA) (mc) | 1/10 | 60 min | R&D Systems |
| Anti-G-CSF (FL-207) sc-13102 (pc) | 1/200 | 60 min | Santa Cruz Biotechnology, Inc. |
| Anti-eNOS (Clone 3/eNOS/NOS Type III) (mc) | 1/20 | 60 min | BD Biosciences |
| Anti-CXCR4 (Clone 44716) (mc) | 1/100 | 60 min | R&D Systems |